Obinutuzumab Plus Bendamustine in Previously Untreated Patients With Chronic Lymphocytic Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia and Lymphoma
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase 2, Multicenter GIBB Study of Obinutuzumab Plus Bendamustine in Previously Untreated Patients With Chronic Lymphocytic Leukemia
Leukemia and Lymphoma 2020 Nov 26;[EPub Ahead of Print], JP Sharman, JM Burke, HA Yimer, MA Boxer, S Babu, J Li, Y Mun, AV DanilovFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.